Drug major Cipla on Wednesday reported a 7 per cent increase in its consolidated net profit at Rs 808 crore in the third quarter ended December 2022, aided by robust sales in the US market.
About the Author
Drug major Cipla on Wednesday reported a 7 per cent increase in its consolidated net profit at Rs 808 crore in the third quarter ended December 2022, aided by robust sales in the US market.
